Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions

被引：0
|
作者：
Drappier, Noemie [1 ]
Pierret, Thomas [2 ]
机构：
[1] Univ Montpellier, Fac Med, F-34090 Montpellier, France
[2] Hosp Civils Lyon, Hop Louis Pradel, Serv Hosp Univ Pneumol, F-69500 Bron, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 12期
关键词：
Non-small cell lung cancer; EGFR exon 20 insertions; Amivantamab; Chemotherapy;
D O I：
10.1016/j.bulcan.2024.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [41] Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab
    de la Fuente, Elena Corral
    Garcia, Maria Eugenia Olmedo
    Martin, Inmaculada Orejana
    Berlinches, Amparo Benito
    Rueda, Ana Gomez
    Alfranca, Yolanda Lage
    Garrido, Pilar
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 5
  • [42] Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).
    Park, Keunchil
    John, Thomas
    Kim, Sang-We
    Lee, Jong Seok
    Shu, Catherine A.
    Kim, Dong-Wan
    Ramirez, Santiago Viteri
    Spira, Alexander, I
    Sabari, Joshua K.
    Han, Ji-Youn
    Trigo, Jose Manuel
    Lee, Chee Khoon
    Lee, Ki Hyeong
    Girard, Nicolas
    Lorenzini, Patricia A.
    Xie, John
    Roshak, Amy
    Thayu, Meena
    Knoblauch, Roland Elmar
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Unraveling Survival Determinants in Patients with Advanced Non-Small-Cell Lung Cancer with EGFR Exon 20 Insertions
    Wang, Kung-Yang
    Chang, Shih-Chieh
    Wei, Yu-Feng
    Hung, Jui-Chi
    Chen, Chung-Yu
    Chang, Cheng-Yu
    CURRENT ONCOLOGY, 2025, 32 (03)
  • [44] EGFR exon20 Insertion Patients Treated with First-Line Chemotherapy in Non-Small Cell Lung Cancer
    Zhao, C.
    Li, X.
    Su, C.
    Chen, X.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S507 - S507
  • [45] Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy
    Kim, Tae Min
    Girard, Nicolas
    Low, Grace Kah Mun
    Zhuo, Jianmin
    Yu, Dae Young
    Yang, Yishen
    Murota, Maiko
    Lim, Cindy Thiow Koon
    Kleinman, Nora J.
    Cho, Byoung Chul
    ACTA ONCOLOGICA, 2023, : 1689 - 1697
  • [46] Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions
    Yang Li
    Yunfeng Ni
    Feng Lv
    Yan Shi
    Yedan Chen
    Xiaoying Wu
    Jiaohui Pang
    Long Huang
    Yang Shao
    Tao Wang
    Jie Min
    Yang Song
    BMC Medicine, 23 (1)
  • [47] Exploratory analysis using serial cell-free DNA in patients treated with amivantamab in non-small cell lung cancer with EGFR exon 20 insertion mutations
    Park, Geun-Ho
    Park, Sehhoon
    Jung, Hyen-Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Lee, Se-Hoon
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Nagasaka, M.
    Goto, K.
    Gomez, J.
    Hida, T.
    Shu, C.
    Lee, C. K.
    Park, K.
    Cho, B. C.
    Lee, J.
    Ou, S.
    Bestvina, C.
    Natale, R.
    Haddish-Berhane, N.
    Bhattacharya, A.
    Verheijen, R.
    Agrawal, T.
    Knoblauch, R.
    Govindan, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1116 - S1116
  • [49] Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
    van Veggel, B.
    van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    De Langen, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Zhang, Jing
    Li, Wenjie
    BMC PULMONARY MEDICINE, 2025, 25 (01):
12345